Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen.
第一作者:
Luigi,Rigacci
第一单位:
Haematology Department, Azienda Ospedaliero Universitaria Careggi, Largo Brambilla, 3, 50139, Florence, Italy, luigi.rigacci@unifi.it.
作者:
医学主题词
成年人(Adult);老年人(Aged);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);环磷酰胺(Cyclophosphamide);剂量效应关系, 药物(Dose-Response Relationship, Drug);多柔比星(Doxorubicin);用药计划表(Drug Administration Schedule);可行性研究(Feasibility Studies);女(雌)性(Female);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);人类(Humans);发病率(Incidence);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);男(雄)性(Male);中年人(Middle Aged);泼尼松(Prednisone);前瞻性研究(Prospective Studies);重组蛋白质类(Recombinant Proteins);危险因素(Risk Factors);血小板减少(Thrombocytopenia);长春新碱(Vincristine);青年人(Young Adult)
DOI
10.1007/s00520-014-2237-9
PMID
24740178
发布时间
2021-10-21
- 浏览10
Supportive care in cancer
2557-61页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



